Cargando…
A panel of DNA methylation markers reveals extensive methylation in histologically benign prostate biopsy cores from cancer patients
BACKGROUND: Men with a negative first prostate biopsy will undergo one or more additional biopsies if they remain at high suspicion of prostate cancer. To date, there are no diagnostic tests capable of identifying patients at risk for a positive diagnosis with the predictive power needed to eliminat...
Autores principales: | Brikun, Igor, Nusskern, Deborah, Gillen, Daniel, Lynn, Amy, Murtagh, Daniel, Feczko, John, Nelson, William G, Freije, Diha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278343/ https://www.ncbi.nlm.nih.gov/pubmed/25548652 http://dx.doi.org/10.1186/s40364-014-0025-9 |
Ejemplares similares
-
An expanded biomarker panel for the detection of prostate cancer from urine DNA
por: Brikun, Igor, et al.
Publicado: (2019) -
A panel of DNA methylation markers for the detection of prostate cancer from FV and DRE urine DNA
por: Brikun, Igor, et al.
Publicado: (2018) -
Breast Cancer Risk and Progressive Histology in Serial Benign Biopsies
por: Visscher, Daniel W., et al.
Publicado: (2017) -
Liquid biopsy, using a novel DNA methylation signature, distinguishes pancreatic adenocarcinoma from benign pancreatic disease
por: Vrba, Lukas, et al.
Publicado: (2022) -
Methylation panel is a diagnostic biomarker for Barrett’s oesophagus in endoscopic biopsies and non-endoscopic cytology specimens
por: Chettouh, Hamza, et al.
Publicado: (2018)